Jerome Winegarden: ASH Continues to Show Exceptional Leadership by Advocating for Patients With Blood Diseases
Jerome Winegarden, Attending Physician and Hematology Oncology Fellowship Program Director at Trinity Health, reposted from American Society of Hematology on LinkedIn:
”ASH continues to show exceptional leadership by advocating for patients with blood diseases.
Standing up for science is not just a great tag line!
It really means something to the millions of people who suffer from blood cancers and blood related diseases.
I’m so proud to be an ASH member.”
Quoting American Society of Hematology‘s post:
”Boldly Standing Up for Science.
2025 brought unprecedented political threats to scientific research, federal funding, and access to care, but hematology thrived.
Through the hashtag Fight 4 Hematology campaign, the Society stepped up to expand research funding and training opportunities, lead impassioned advocacy efforts, and amplify the voices of clinicians, researchers, and patients.
ASH is proud to serve hematologists who are dedicated to conquering blood diseases and improving the lives of patients around the world.
Thank you for being an ASH member and helping to make 2025 such a success!
View the 2025 ASH Annual Report.”
Stay updated with Hemostasis Today.
-
Mar 20, 2026, 16:28Breanna Beers: A Remarkable Case of ‘Generation Skipping’ Marfan Syndrome
-
Mar 20, 2026, 16:26Results from The HUNT Study on The Role of Plasma miR-145-5p Levels in Cancer-Associated VTE – JTH
-
Mar 20, 2026, 16:23Eva Soler Espejo։ Atherogenic Index of Plasma and Residual Risk in Atrial Fibrillation
-
Mar 20, 2026, 16:22Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
-
Mar 20, 2026, 16:21Maxime Dely: The Lifesaving Power of Plasma Donations
-
Mar 20, 2026, 16:20Yves Bikorimana: Hemolysis – Why It Ruins Laboratory Results
-
Mar 20, 2026, 16:19Simon Senanu: G6PD Deficiency Testing – What the Lab Must Get Right
-
Mar 20, 2026, 16:18Khaled Elshazly: Can We Stop Chemotherapy-Induced Thrombocytopenia from Delaying Treatment?
-
Mar 20, 2026, 15:50Rithwic Mani: Platelet-to-Lymphocyte Ratio as A Simple and Cost-Effective Prognostic Biomarker in Stroke